Loading...
Market
Which organization will be the next to recommend MVA-BN vaccine?
2
Resolution / Starting Odds
CDC • 25%
EMA • 25%
FDA • 25%
Other • 25%
Official announcements from relevant organizations
Story
WHO Prequalifies Bavarian Nordic's MVA-BN Vaccine as First Mpox Shot on Friday, Approved in Mexico
Sep 13, 2024, 09:45 AM
The World Health Organization (WHO) has prequalified the MVA-BN vaccine, developed by Bavarian Nordic, as the first vaccine against mpox. This approval, announced on Friday, marks a significant step towards expanding access and reducing transmission in high-risk communities. Additionally, the vaccine has been approved for emergency use in Mexico by Cofepris.
View original story
Similar markets
CDC • 25%
WHO • 25%
European Medicines Agency • 25%
Other • 25%
Yes • 50%
No • 50%
Approved without conditions • 25%
Approved with conditions • 25%
Not approved • 25%
Decision delayed • 25%
United States • 25%
Germany • 25%
Brazil • 25%
India • 25%
Yes • 50%
No • 50%
Nigeria • 25%
Democratic Republic of Congo • 25%
Kenya • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
GeoVax COVID-19 vaccine • 33%
Moderna mRNA influenza vaccine • 33%
Pfizer COVID-19 vaccine • 33%
Yes • 50%
No • 50%
Africa • 25%
Asia • 25%
Latin America • 25%
Other • 25%